References
- Fact sheet N297 on cancer [http://www.who.int/mediacentre/factsheets/fs297/en/print.html]
- EustachiAComplementary Therapies in Breast Cancer PatientsBreast Care200724209216
- KiddPMThe use of mushroom glucans and proteoglycans in cancer treatmentAltern Med Rev20005142710696116
- TsangKWLamCLYanCCoriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancerRespir Med200397661862412814145
- WongLYTangJLLeungPCPrevalence and attitude of complementary and alternative medicine by healthy people in Hong KongThe 4th TWGHs-CUHK Eddie Wang Symposium on Complementary Chinese and Western Medicine-Integrated Approach 2004Hong Kong: TWGHs 2004115
- ShiuWCTLeungTWTTaoMA clinical study of PSP on peripheral blood counts during chemotherapyPhytother Res199264217218
- SunZYLiuJXThe clinical efficacy of PSP in 485 cancer patients: A double blind studyChinese Medicine and Public Health, No 23–24Hong KongUniversity of Hong Kong1996
- WongCKLeungKNFungKPChoyYMImmunomodulatory and anti-tumor polysaccharides from medicinal plantsJ Int Med Res1994222993127895893
- CaoEHLiuXQWangJJXuNFEffect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cellsFree Radic Biol Med19962068018068728027
- de la FuenteMFerrandezMDBurgosMSSolerAPrietoAMiquelJImmune function in aged women is improved by ingestion of vitamins C and ECan J Physiol Pharmacol19987643733809795745
- WongCKBaoYXWongELYLeungPCFungKPLamCWKImmunomodulatory activities of yunzhi and danshen in post-treatment breast cancer patientsAm J Chin Med200533338139516047556
- WongCKTsePSWongELYLeungPCFungKPLamCWKImmunomodulatory effects of Yun Zhi and danshen capsules in healthy subjects – a randomized, double-blind, placebo-controlled, crossover studyInt J Immunopharmacol200442201211
- BaoYXWongCKLeungSFClinical studies of immunomodulatory activities of yunzhi-danshen in patients with nasopharyngeal carcinomaJ Altern Complement Med200612877177617034283
- WoodwardWAStromEATuckerSLChanges in the 2003 American Joint Committee on Cancer Staging for Breast Cancer Dramatically Affect Stage-Specific SurvivalJ Clin Oncol200321173244324812947058
- HelgessonOLissnerLManssonJBengtssonCQuality of life in cancer survivors as observed in a population study of Swedish womenScand J Prim Health Care200725422022517924285
- JanzNKMujahidMChungLKSymptom experience and quality of life of women following breast cancer treatmentJ Womens Health (Larchmt)20071691348136118001192
- RampesHJamesRComplications of acupunctureAcupunct Med19951312633
- TamKTheory of Chinese MedicineTaiwanCheng Chung Book Co. Ltd.1998
- LamCLKGandekBRenXSChanMSTests of scaling assumptions and construct validity of the Chinese (Hong Kong) version of the SF-36 health surveyJ Clin Epidemiol199851113911479817131
- LamCLKLauderIJLamTPGandekBPopulation based norming of the Chinese (Hong Kong) version of the SF-36 health surveyHK Pract199921460470
- MorimotoTOgawaMOritaKPostoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of JapanEur J Cancer199632A2352428664034
- SunTWZhuYPThe effect of PSP on immune function and living quality in patients receiving chemotherapy for gynecological malignanciesAdvanced Research in PSPYangQYHong KongThe Hong Kong Association for Health Care1999
- ChaiZKShenHMYunzhi polysaccharopeptide capsule III period clinical researchAdvanced Research in PSPYangQYHong KongThe Hong Kong Association for Health Care19992550